Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Interest Expenses (2016 - 2018)

Armata Pharmaceuticals' Interest Expenses history spans 6 years, with the latest figure at $337000.0 for Q4 2018.

  • For Q4 2018, Interest Expenses changed N/A year-over-year to $337000.0; the TTM value through Dec 2018 reached $644000.0, up 64300.0%, while the annual FY2024 figure was $10.7 million, 309.06% up from the prior year.
  • Interest Expenses for Q4 2018 was $337000.0 at Armata Pharmaceuticals, up from $307000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $8.8 million in Q1 2014 and bottomed at -$204000.0 in Q3 2016.
  • The 5-year median for Interest Expenses is $317000.0 (2016), against an average of $1.3 million.
  • The largest annual shift saw Interest Expenses skyrocketed 9038.54% in 2014 before it crashed 95.09% in 2015.
  • A 5-year view of Interest Expenses shows it stood at $8.8 million in 2014, then plummeted by 95.09% to $431000.0 in 2015, then dropped by 24.13% to $327000.0 in 2016, then crashed by 99.69% to $1000.0 in 2017, then surged by 33600.0% to $337000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Interest Expenses are $337000.0 (Q4 2018), $307000.0 (Q3 2018), and $1000.0 (Q1 2017).